8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Macrolide treatment failure in a case of secondary syphilis: a novel A2059G mutation in the 23S rRNA gene of Treponema pallidum subsp. pallidum.

      Journal of Medical Microbiology
      Adolescent, Adult, Animals, Anti-Bacterial Agents, pharmacology, therapeutic use, Child, Child, Preschool, Czech Republic, epidemiology, DNA, Bacterial, analysis, isolation & purification, Drug Resistance, Bacterial, genetics, Humans, Infant, Infant, Newborn, Macrolides, Male, Middle Aged, Mutation, Prevalence, RNA, Ribosomal, 23S, Rabbits, Sequence Analysis, DNA, Spiramycin, Syphilis, drug therapy, microbiology, Treatment Failure, Treponema pallidum, drug effects, Young Adult

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We report an occurrence of treatment failure after oral spiramycin therapy in a man with secondary syphilis and a reported penicillin and tetracycline allergy. Molecular detection revealed treponemal DNA in the blood of the patient and sequencing of the 23S rDNA identified an A to G transition at the gene position corresponding to position 2059 in the Escherichia coli 23S rRNA gene. The occurrence of this novel 23S rDNA mutation was examined among 7 rabbit-propagated syphilitic strains of Treponema pallidum and among 22 syphilis patient isolates from the Czech Republic. The prevalence of A2058G and A2059G mutations among clinical specimens was 18.2 and 18.2 %, respectively.

          Related collections

          Author and article information

          Comments

          Comment on this article